Inhaled triiodothyronine (T3)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Inhaled triiodothyronine (T3), covering 2026-02-10 to 2026-02-10. Get the full timeline:
Most recent: Clinical Trial Update: Direct Topical Lung T3 Treatment to Improve Outcome & Sequelae of COVID-19 Acute Respiratory Distress Syndrome [Phase 2]